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Abstract
Background: Understanding the molecular mechanisms controlling pluripotency in embryonic stem cells (ESCs) is of central
importance towards realizing their potentials in medicine and science. Cross-species examination of transcriptional co-
expression allows elucidation of fundamental and species-specific mechanisms regulating ESC self-renewal or
differentiation.
Methodology/Principal Findings: We examined transcriptional co-expression of ESCs from pathways to global networks
under the framework of human-mouse comparisons. Using generalized singular value decomposition and comparative
partition around medoids algorithms, evolutionarily conserved and divergent transcriptional co-expression regulating
pluripotency were identified from ESC-critical pathways including ACTIVIN/NODAL, ATK/PTEN, BMP, CELL CYCLE, JAK/STAT,
PI3K, TGFb and WNT. A set of transcription factors, including FOX, GATA, MYB, NANOG, OCT, PAX, SOX and STAT, and the
FGF response element were identified that represent key regulators underlying the transcriptional co-expression. By
transcriptional intervention conducted in silico, dynamic behavior of pathways was examined, which demonstrate how
much and in which specific ways each gene or gene combination effects the behavior transition of a pathway in response to
ESC differentiation or pluripotency induction. The global co-expression networks of ESCs were dominated by highly
connected hub genes such as IGF2, JARID2, LCK, MYCN, NASP, OCT4, ORC1L, PHC1 and RUVBL1, which are possibly critical in
determining the fate of ESCs.
Conclusions/Significance: Through these studies, evolutionary conservation at genomic, transcriptomic, and network levels
is shown to be an effective predictor of molecular factors and mechanisms controlling ESC development. Various
hypotheses regarding mechanisms controlling ESC development were generated, which could be further validated by in
vitro experiments. Our findings shed light on the systems-level understanding of how ESC differentiation or pluripotency
arises from the connectivity or networks of genes, and provide a ‘‘road-map’’ for further experimental investigation.
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Introduction
Embryonic stem cells (ESCs) are pluripotent; they can replicate
indefinitely and differentiate into multiple tissues from all three
embryonic germ layers. Due to their unique properties, ESCs
serve as a model system for studying embryo development and
hold great promise for regenerative medicine [1,2]. An under-
standing of the molecular mechanisms regulating pluripotency of
ESCs is critical in realizing their therapeutic and biological
potentials. Previous studies examining differentially expressed
genes in ESCs and their early-differentiated counterparts,
embryoid bodies (EBs), have begun to identify the molecular
signatures of ESCs and elucidate the mechanisms controlling
pluripotency [3–7]. Yet, significant differences exist among ESCs
harvested from different species [8–10], suggesting that cross-
species analysis may help distinguish between fundamental and
species-specific mechanisms regulating ESC development. We
previously conducted a human-mouse comparative genomics
study on pathways critical for ESC self-renewal and differentiation
[11]. The study demonstrates that the pathways directed by FGF,
NANOG, NODAL, OCT4 and SOX2 are evolutionarily
conserved as the component genes are conserved on both the
gene and promoter structure. The LIF pathway is, on the other
hand, evolutionarily divergent from the genomic perspectives. The
study suggests that the conserved OCT4/SOX2 synergistic action
is an important activation mechanism in the FGF, LIF, NANOG
and OCT4 directed pathways, which are furthermore regulated
by a feedback loop formed by ESG1, FOXD3 and SOX2. FGF
may regulate ESG1, FOXD3 and SOX2 in a parallel pathway to
maintain ESC self-renewal. We have also conducted a compar-
ative transcriptomics study on ESCs, which examined a large set of
biological pathways and processes, as well as transcription factors
and growth factors expressed in ESCs [12]. In that study, embryo
development, pattern specification, cell cycle, apoptosis, NOTCH,
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conserved as the genes of these pathways show a significant cross-
species correlation on the transcriptional response to ESC
differentiation. Transcription or growth factors such as GDF3,
LEFTB, MYB, MYCN, NFYB, POLR3K, POU2F1, TDFG1 and
UTF1 are also conserved in the transcriptional response to ESC
differentiation. These conserved pathways and factors may
represent fundamental molecular mechanisms regulating ESC
pluripotency. These and other cross-species genomic and
transcriptomic studies establish a functional portrait of ESCs
[3,8,11–15].
Most studies on ESC transcriptomes focus primarily on fold
changes of individual genes while overlooking concerted tran-
scriptional changes of genes. It has been shown that modular and
dynamic behaviors of gene expression are important mechanisms
used by cells in functional regulation [16–19]. Various studies have
demonstrated the significance of examining gene co-expression in
addressing biological problems [20–24]. Cross-species analysis of
transcriptional co-expression, which has never been conducted on
ESCs, will facilitate the understanding of the large-scale
organization and evolution of the ESC transcriptome and the
molecular mechanisms of pluripotency.
In this study, we further the cross-species comparative
investigation of ESCs by exploring transcriptional co-expression
or modulation from pathways to global networks. We first
employed generalized single value decomposition (GSVD) and
comparative partition around medoids (cPAM) methods for
cross-species analysis of gene co-expression in ESC-critical
pathways, including ACTIVIN/NODAL, ATK/PTEN, BMP,
CELL CYCLE, JAK/STAT, PI3K, TGFb, and WNT. Com-
plexes of co-expressed genes that were conserved across species
or unique to a single species were identified, suggesting the
existence of fundamental or species-specific modulation of gene
expression controlling ESC pluripotency. The results suggest an
essential role of JAK-mediated signaling through activating
STAT2 and PI3K in ESCs, while reaffirming different
requirements of STAT3-mediated LIF signaling in mouse and
human ESCs. The mechanisms of WNT signaling seem to be
different in human and mouse ESCs as the pathway showed
differential co-expression among the key component genes across
species. The AKT/PTEN pathway showed a high co-expression
among the key members in both species, suggesting its
fundamental role in ESC development. By promoter analysis,
we identified binding sites of a set of transcription factors,
including FOX, GATA, MYB, NANOG, OCT, PAX, SOX and
STAT, as well the FGF response element, which may represent
key regulatory mechanisms underlying the conserved co-
expression in the ESC-critical pathways. By transcriptional
interventions conducted in silico, we showed how each gene or
gene combination influences pathway transitions in response to
ESC differentiation or pluripotency induction. Finally, we
constructed global co-expression networks of ESCs, which were
dominated by a few highly-connected genes (hub genes) that link
the less-connected genes to the system. The hub genes, including
I G F 2 ,J A R I D 2 ,L C K ,M Y C N ,N A S P ,O C T 4 ,O R C 1 L ,P H C 1
and RUVBL1, are possibly critical in determining the fate of
ESCs. Our studies demonstrate that evolutionary conservation at
genomic, transcriptomic, and network levels is an effective
predictor of molecular factors and mechanisms controlling ESC
development. The findings and methods presented by the studies
shed light on the systems understanding of how genes interact
with each other to perform ESC-related functions and how ESC
pluripotency or differentiation arises from the connectivity or
networks of genes.
Results
We utilized multiple microarray datasets obtained from
undifferentiated ESCs and differentiated EBs of human and
mouse for cross-species examination of transcriptional co-expres-
sion. Fundamental and species-specific mechanisms regulating
ESC pluripotency were examined from conserved and divergent
co-expression patterns in ESC-critical pathways and from
transcription factors underlying the co-expression. Pathway
dynamics behavior in response to ESC differentiation or
pluripotency induction was determined through a series of
transcriptional intervention conducted in silico. The global co-
expression network furthermore sheds light on the overall
organization of transcriptomes in ESCs.
1. Pathway-specific co-expression profiles
By employing GSVD and cPAM algorithms, we conducted
human-mouse comparative analyses on transcriptional co-expres-
sion in ACTIVIN/NODAL, AKT/PTEN, BMP, CELL CYCLE,
JAK/STAT, PI3K, TGFb and WNT pathways. These pathways
are known to be critical for ESC self-renewal and differentiation
[13,25]. Taking the cell cycle as an example, we examined 356
genes of this pathway that are orthologous between human and
mouse genomes and expressed in ESCs and EBs (Table S1).
Figures 1-A and B illustrate the GSVD analysis. Each eigengene,
computed as a linear combination of genes, represented common
features between two datasets and provided a basis for identifying
co-expression patterns conserved across species (Figure 1-A).
Among them, the eigengene 3 showed the smallest difference
between the two singular values that it was associated with
(Figure 1-B), suggesting that this eigengene had nearly equal
contribution to the variance of human and mouse datasets. We
subsequently projected the human and mouse gene expression
data onto the space of this eigengene, which led to the
identification of two cross-species conserved co-expression gene
clusters, C1 and C2 (Table S1). Figure 1-C illustrates the cPAM
analysis, with the results summarized in <tblref rids="‘, the
conserved cluster O2 was identified. The conserved co-expression
clusters identified by cPAM were largely similar to those by
GSVD: O1 corresponded to the C1 cluster, and O2 to the C2
cluster (Table S1). By integrating together the results by the two
methods, we determined the final ranges of O1 (49 genes, average
r=0.523 in human and 0.717 in mouse cells) and O2 (81 genes,
average r=0.747 and 0.851) (Table 1, details in Table S1). In
total, 44% or 58% of the genes showed co-expression in human or
mouse cells (i.e. members of clusters H1 and H2, or M1 and M2),
and 37% showed conserved co-expression (i.e. members of clusters
O1 and O2). The genes in H1, M1 and O1 were down-regulated
in ESCs, while the genes in H2, M2, and O2 were up-regulated in
ESCs (Figure 1-D). The co-expression in each of these gene
clusters is statistically significant, beyond random expectation (P
value,0.01). We finally mapped the revealed co-expression and
expression patterns onto the core network of the cell cycle to
further examine how the transcriptional modulation is involved in
the core activities of the cell cycle in ESCs. As shown in Figure 1-
E, within the core network, genes mostly showed conserved co-
expression. Outside the core network, however, genes mostly
showed divergent co-expression (supplementary Table S1). The
analyses yielded important insights into how the cell cycle genes
function through transcriptional modulation or network to control
pluripotency (see details in Discussion).
The co-expression analyses on other ESC-critical pathways
were conducted in the same way as on the cell cycle. The results of
GSVD and cPAM analyses, as well as the heatmaps of the
Co-Expression in Stem Cells
PLoS ONE | www.plosone.org 2 October 2007 | Volume 3 | Issue 10 | e3406Figure 1. The identification of conserved and divergent co-expression gene clusters in the cell cycle from human and mouse ESC-
EB data. The analysis results for AKT/PTEN, JAK/STAT, TGFb, WNT and other pathways are presented in supplementary Figures S1 through S4. A)
Heatmap display of the tailing matrix shared between human and mouse data by GSVD. The expression of each eigengene (rows) across all ESC and
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S3 and S4, and summarized in Table 1. As shown, two tightly co-
expressed gene clusters were identified from each pathway: H1
and H2 from human cells and M1 and M2 from mouse cells. From
the H1 - M1 and H2 - M2 overlappings across species, conserved
co-expression clusters O1 and O2 were further identified,
respectively. The identification of conserved co-expression clusters
was largely consistent between GSVD and cPAM analyses. The
final ranges of the conserved clusters were determined by
integrating the results by both methods. The co-expression in
each gene cluster was statistically significant (P value,0.001). The
identification of the conserved co-expression clusters is particularly
reliable as they are observed from different species. The mapping
of the revealed co-expression and expression patterns on core
networks of the pathways are shown in Figure S1-E through S4-E.
Detailed information regarding the genes examined in each
pathway, their expression patterns and classification into co-
expression clusters is provided in Table S1.
2. Transcription factors underlying co-expression
Genes with correlated expression profiles are likely to have their
promoter regions bound by common transcription factors and
regulated through common regulatory mechanisms [26]. By
promoter sequence analysis, we sought to uncover potential
transcription factors underlying the transcriptional co-expression
in the ESC-critical pathways. Table 2 lists the transcription factors
that showed binding sites in most genes of both human and mouse
and were statistically over-represented in each conserved co-
expression cluster of the ESC-critical pathways (P value,0.01)
(details in Table S2). The identification of these transcription
factors should be highly reliable because it is based on the
evolutionary conservation of not only genomic sequences but also
transcriptomic co-expression. Among the ‘‘conserved’’ transcrip-
tion factors, some seemed to be pathway specific as they were
present only in one or two pathways (e.g. CART1, ETF, RUSH-
1a, SF1 and SOX9), while others were present in all or most of the
pathways and may represent common regulators of conserved
transcriptional co-expression among different pathways. Among
the latter ‘‘conserved’’ and ‘‘common’’ transcription factors, some
bear no overt relationship to ESC development and may serve as
new candidates for further investigation. Others have been
implicated in ESC self-renewal or differentiation. For example,
OCT4, SOX2 and NANOG form the central regulatory circuitry
in ESCs [27,28]. ETS and TCF/LEF, on the other hand, are
effectors of ESC-critical FGF/RAS/MAPK and canonical WNT
pathways [25,29,30]. Interestingly, the binding sites of ETS and
TCF/LEF were often adjacent to each other on the promoter
sequences of co-expressed genes in these pathways (Figure 2). Such
juxtaposed ETS and TCF/LEF binding motifs on the promoter
are referred to as the FGF response element (FRE) [31]. Being
associated with most human and mouse genes in all conserved co-
expression clusters of the ESC-critical pathways, the FRE appears
to be evolutionary conserved and hence fundamental in regulating
transcriptional modulation important to ESC development. FREs
are also present on the regulatory region of SOX2 [11]. Moreover,
the cognate motif of SOX2 (CA/TTTGTT) is similar to that of
TCF/LEF (CTTTGA/TA/T). This raises the possibility that
SOX2 competes with TCF/LEF on the FRE in cooperation with
ETS proteins, or TCF/LEF competes with SOX2 on the target
genes of the SOX2/OCT4/NANOG co-binding. Taken together,
FGF activating the FRE may integrate with ACTIVIN/NODAL,
ATK/PTEN, BMP, CELL CYCLE, JAK/STAT, PI3K, TGFb
and WNT pathways, as well as the SOX2/OCT4/NANOG
regulatory circuitry, in determining the fate of ESCs.
More transcription factors are possible which underline the co-
expression in the ESC-critical pathways, since the transcription
factor database (i.e. Transfac) is not yet complete in the coverage of
binding motif data. On the other hand, computationally identified
transcription factor binding sites may not be all functionally active
in cells, and ultimate experimental validation of the results is
necessary.
3. Dynamic response of pathways to ESC differentiation
and pluripotency induction
Biological pathways are dynamic and behave only in certain
ways and controlled manners during development and in response
to external factors [17,22,32]. To further explore the mechanisms
controlling ESC pluripotency, we conducted a series of transcrip-
tional interventions in silico on every gene or gene combination to
model the dynamic behavior of pathways in transitions between
ESC and EB states. In the transcription intervention, the initial
expression of each gene was altered to its opposite direction (i.e.
from initial up-regulation to down-regulation, or from down- to
up-regulation) or to keep the direction the same. Three different
kinds of transcriptional interventions were conducted: a) single-
gene intervention, b) double-gene intervention, and c) triple-gene
intervention (See Methods). The probabilities of network transition
from the ESC to EB state and from the EB to ESC state in
response to these interventions were then calculated. The genes or
gene combinations showing high probabilities of the ESC-to-EB
network transition were regarded as highly contributive to ESC
differentiation, while genes showing high probabilities in the EB-
to-ESC network transition were regarded as highly contributive to
ESC self-renewal or pluripotency induction from differentiated
cells. The highly contributive genes or gene combinations and
their intervened transcriptional patterns provide clues for which
EB samples of both datasets (columns) is illustrated by the red-to-green color gradient representing high-to-low values. The matrix was normalized in
such that all rows had the length of 1. B) Bar chart of the angular distance between singular values that shows the difference of eigengene’s
contribution to the total variances of human and mouse datasets. The eigengene 3 showed the smallest angular distance, indicating its almost equal
contribution to the two datasets, thus used to derive conserved gene clusters across species. C) Correlation matrix of genes based on their expression
profiles in human cells (the lower-left triangle part) and mouse cells (the upper-right triangle part), resulted from cPAM. The light-to-dense color
gradient on the graph represents low-to-high correlation between genes. The genes are listed on the horizontal and vertical axes in the same order
that was determined according to the clustering by PAM. The genes were clustered into H1 and H2 in human and M1 and M2 in mouse. The
conserved co-expression cluster O1 was identified from the H1 - M1 overlapping, and the conserved co-expression cluster O2 was identified from the
H2 - M2 overlapping. D) Heatmap display of the normalized expression values of the genes presented in the correlation matrix, with the genes listed
in the same order. The green-to-red color gradient represents down-to-up regulation of a gene in comparison to the mean expression value across all
samples. The genes in H1, M1 and O1 clusters were down-regulated, while the genes in H2, M2 and O2 were up-regulated in undifferentiated ESCs. E)
Core network of the pathway with illustration of expression and co-expression patterns. The genes showing co-expression in both human and mouse
cells are labeled red or green (representing up- or down-regulation in undifferentiated ESCs), the genes showing co-expression in one species but not
in another are labeled blue, and the genes showing no co-expression in both human and mouse cells are labeled yellow.
doi:10.1371/journal.pone.0003406.g001
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directed-differentiation of ESCs or for pluripotency maintenance
or induction.
We selected JAK/STAT and WNT pathways for dynamic
behavior analysis. The two pathways are critical to human and
mouse ESCs, but present different intra-pathway co-expression
patterns and possibly different regulatory mechanisms between
species (see Discussion). The expression patterns of the genes in
these pathways and the pathway topologies are shown in Table S1,
Figures S1-E and S2-E.
JAK/STAT pathway. We examined the dynamic behavior
based on the following key component genes of this pathway:
CISH, JAK1, PIAS2, PIM1, STAM, STAT2, STAT3, SOCS2
(in mouse) or SOCS1 (in human), and SOCS5 (showing a
different expression pattern from that of SOCS1 and SOCS2).
The probabilities were calculated for the pathway transitions in
response to 27 single-, 324 double- and 2,268 triple-gene
interventions introduced on these genes. The results are shown
in Figure 3 (details in Table S3). In both human and mouse cells,
PIAS2 appears to be the most contributive gene to both ESC-to-
EB and EB-to-ESC transitions, followed by STAT2 and JAK1
(in human) or CISH (in mouse). In other words, among all the
genes, PIAS2 would the most likely cause the ESC-to-EB
transition of the pathway behavior (probability 0.0035 in human
and 0.014 in mouse) when its initial transcription state of up-
regulation in ESCs is altered to down-regulation (Table S3).
PIAS2 would also the most likely cause the EB-to-ESC transition
of this pathway (probability 0.0028 in human and 0.021 in
mouse) when its initial down-regulation in EBs is altered to up-
regulation. Double- and triple-gene combinations in which
PIAS2 was involved also showed a high transition probability
in both directions when the transcription of these genes was
altered. PIAS2 is an inhibitor of STAT, negatively regulating
JAK/STAT signaling, along with the feedback loops of SOCS
and CISH (Figure S2-E). Because of the high impact of PIAS2
on the dynamic behavior of this pathway, the knockout of this
gene in ESCs may facilitate differentiation of ESCs, while
increased PIAS2 production may enhance the self-renewal of
ESCs or benefit induction of a differentiated cell to the
pluripotent state. We furthermore found that in both human
and mouse cells, the total of the transition probabilities by all
single-gene interventions, as well as that by all double-gene
interventions or by triple-gene interventions, was similar between
the ESC-to-EB transition and the EB-to-ESC transition (Table 3).
The result suggests that the JAK/STAT pathway is equally
contributive to ESC differentiation (e.g. from ESCs to EBs) and
to pluripotency maintenance or induction (e.g. from EBs to
ESCs).
WNT pathway. Totally 30 single-, 395 double-, and 3,240
triple-gene interventions were conducted on key component
genes of this pathway, including CSNK1E, CTNNB1 (b-
C a t e n i n ) ,D K K 1 ,G S K 3 B ,L E F 1 ,L R P 6 ,P S E N 1 ,D V L 2( i n
mouse) or DVL3 (in human), FZD1 (in human) or FZD4 (in
mouse), and FZD5 (showing a different expression pattern from
that of FZD1 and FZD4). As shown in Figure 3 (details in Table
S3), in both human and mouse cells, DKK1 showed the highest
probability in both ESC-to-EB and EB-to-ESC transitions,
followed by PSEN1, by single-gene intervention. The DKK1/
PSEN1 combination showed the highest probability in
transitions of both directions by double-gene intervention. The
triple-gene combinations in which DKK1 and PSEN1 were
involved furthermore showed high probabilities in pathway
transitions on both directions. DKK1 is an inhibitor of LRP and
further to the activity of the receptor FZD, while PSEN1 is an
inhibitor to b-Catenin (Figure S1-E). Both DKK1 and PSEN1
were down-regulated in ESCs. Our results indicate that
transcriptional changes of these two genes in either ESCs or
EBs would the most likely alter the fate of the cells toward either
ESC differentiation or pluripotency induction. The WNT
Table 1. Summary of the identification of co-expression gene
clusters in ESC-critical pathways by GSVD and cPAM. O1 and














Cell Cycle 356 H1 60 0.473 Down
H2 96 0.747 Up
M1 84 0.676 Down
M2 123 0.837 Up
O1 49 0.523 (H) Down
0.717 (M)
O2 81 0.747 (H) Up
0.851 (M)
WNT 92 H1 17 0.645 Up
H2 19 0.59 Down
M1 25 0.558 Up
M2 40 0.607 Down
O1 10 0.713 (H) Up
0.600 (M)
O2 14 0.596 (H) Down
0.715 (M)
JAK/STAT 58 H1 19 0.581 Down
H2 9 0.519 Up
M1 22 0.658 Down
M2 12 0.663 Up
O1 15 0.610 (H) Down
0.674 (M)
O2 7 0.691 (H) Up
0.746 (M)
TGFb 54 H1 21 0.534 Down
H2 3 0.861 Up
M1 30 0.562 Down
M2 16 0.49 Up
O1 17 0.520 (H) Down
0.611 (M)
O2 3 0.861 (H) Up
0.915 (M)
AKT/PTEN 63 H1 13 0.539 Up
H2 18 0.601 Down
M1 16 0.483 Up
M2 23 0.555 Down
O1 7 0.597 (H) Up
0.550 (M)
O2 12 0.637 (H) Down
0.675 (M)
doi:10.1371/journal.pone.0003406.t001
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mouse ESCs on the dynamic behavior, despite the similarity. In
human cells, the probability of the ESC-to-EB transition was
much higher than that of EB-to-ESC transition. In mouse cells,
however, the probability was similar between the ESC-to-EB
transition and the EB-to-ESC transition. For example, DKK1
and PSEN1, the most contributive genes to network transitions
in both species, showed nearly 100-fold higher probabilities in
the ESC-to-EB transition than the EB-to-ESC transition in
human cells, but showed similar probabilities between the two
transitions in mouse cells (Figure 3, details in Table S3).
Moreover, the sum of all probabilities was higher in the ESC-
to-EB transition than the EB-to-ESC transition in single-,
double-, or triple-gene interventions for human cells, while
there was little difference between the two transitions in mouse
cells (Table 3). The results suggest that the WNT pathway is
more contributive to ESC differentiation than pluripotency
maintenance or induction in humans, while equally contributive
in determining two different cell fates in mice.
The dynamical behavior of signal pathways is highly
complicated; many ligands, homologous genes, alternative splice
variants and regulatory factors are involved in the signaling, and
different pathways further interact or cross-talk with one others,
all together impacting the dynamic response to ESC differenti-
ation or self-renewal. Our analysis, based on the key component
genes and well-defined network topology to demonstrate main
patterns of dynamic behavior, represents an important first step
and a novel approach in systems understanding of mechanisms
controlling ESC self-renewal and differentiation.
4. Global co-expression network of ESCs
Using genome-wide expression data of ESCs and EBs, we
constructed global co-expression networks related to the early
differentiation of human and mouse ESCs (hESCs, mESCs). A
co-expression network consists of nodes representing genes and
links representing co-expression between the genes. We calcu-
lated the correlation (r) between each gene according to their
expression profiles, and determined the co-expression links on
the network if r was above the threshold value. The threshold r
value 0.80 (for hESCs) or 0.90 (for mESCs) that we chose
corresponded to the linear regression model fitting index R
2
value 0.84 or above, which suggests scale-free topology of the
resulting network. The finally constructed co-expression net-
works of hESCs and mESCs consisted of 6,118 and 4,120 genes,
respectively. Based on the overlapping or shared components
between the hESC and mESC co-expression networks, we
further constructed a hESC-mESC conserved co-expression
network, which consisted of 55,712 genes. Similar to hESC
and mESC networks, the hESC-mESC conserved network was
also scale-free (R
2 0.75). The scale-free property, a common
features among biological networks [18,21,33,34], suggests that
the topology of the ESC co-expression networks is dominated by
a few highly-connected genes (hub genes) that link the less-
connected genes to the system. The hub genes on biological
networks are often vital and associated with lethal knockout
phenotypes or critical biological functions [35]. It is expectable
that the scale-free ESC co-expression networks are robust to the
random deletion on most genes while sensitive to the targeted
attack on hub genes. We furthermore found that the ESC co-
expression networks were significantly associated with biological
functions, through an assessment of functional similarities
between co-expressed genes in the networks in comparison to
random genes (Figure 4). Interestingly, the hESC-mESC
conserved network showed a stronger functional association
than other networks, suggesting that natural selection favors the
co-expressed gene pairs that are functionally coupled over those
with loose functional association in the networks. Table S4 lists
the genes on the networks, along with their network connectivity
(i.e. the number of connected genes for each gene on the
network) and expression patterns in ESCs and EBs. Figure S5
shows the topology of the conserved network, with illustration of
hub genes.
Tables 4-A and B list top hub genes and hub transcription
factors identified from the hESC-mESC conserved co-expression
network (Table S4 for details). Interestingly, all the hub genes or
hub transcriptional factors showed significant changes of the
expression level between ESCs and EBs (adjusted P value#0.05).
Many of the hub genes were related to the cell cycle, development,
and signaling pathways important for ESC development. For
example, ORC1L and ORC2L are essential for the initiation of
the DNA replication. RUVBL1, evolutionarily highly conserved
and essential for viability in the yeast, flies and worms [36], plays a
important role in c-MYC and WNT signaling pathways [37–39],
and in DNA repair, chromatin remodeling and apoptosis [40,41].
NASP, an H1 histone binding protein, may regulate early events
of spermatogenesis [42]. JARID2 is involved in mouse embryo-
genesis by showing embryogenesis-specific expression, and partic-
ipates in the negative regulation of cell proliferation signaling
[43,44]. Some hub genes, such as IGF2, LCK and PHC1, have
been implicated in ESC self-renewal and differentiation. PHC1,
for example, is located adjacent to genes on human chromosome
12 which are hallmarks of stem cells, including CD9, GDF3,
GLUT3, NANOG, SCNN1A and STELLA [45]. The target
genes of PHC1 are transcriptionally repressed in ESCs to maintain
pluripotency while preferentially activated during ESC differenti-
ation [46,47]. LCK is one of the SRC genes, which are implicated
in maintaining pluripotency in mESCs [48,49]. IGF2, an insulin
growth factor, shows aberrant genomic imprinting, abnormal
hypermethylation and an altered epigenetic status in ESCs
[50,51]. Among the hub transcription factors, HAND1, HMGA1,
MYCN and OCT4 are known to be important for stem cell
development [27,52–54]. HOPX, NFYB, TFAM, TGIF1,
Table 2. ‘‘Conserved’’ transcription factors which showed binding sites among most genes of both human and mouse and
statistically over-represented in conserved co-expression clusters.
Conserved transcription factors
Present in all the 5 pathways OCT1; OCT4; CDP; CDXA; ETS; GATA4; MRF2; NCX; NKX2-5; POU3F2; SPZ1; SREBP1; SRY; TBX5; TST1; TTF1;
VDR; ZF5; ZIC2; AP2; DBP; MAF; MAZ; MYB; RFX; SP3; TCF11; HAND1; E47; HNF-3ALPHA; HNF-4ALPHA; PAX;
SREBP; FOX; LEF1TCF1; STAT; TEL2; NANOG
Present in only 1–2 pathways ETF; RUSH-1ALPHA; SF1; SOX9; AR; CART1; COUP; IPF1; KROX; LXR; LYF1; MYOD; NF1; PEBP; SMAD3; SZF1-1
The transcriptional factors were identified from 5 pathways: AKT/PTEN, CELL CYCLE, JAK/STAT (incl. PI3K), TGFb (incl. ACTIVIN/NODAL and BMP), and WNT.
doi:10.1371/journal.pone.0003406.t002
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Such hub transcription factors or hub genes may serve as new
candidates in future investigations of ESCs.
Discussion
Our human-mouse comparative examination on ESCs
identified evolutionarily conserved and divergent co-expression
patterns in ESC-critical pathways, which provide insight into
fundamental and specific molecular mechanisms controlling
ESC pluripotency.
Cell Cycle
The cell cycle is a critical process involved in ESC development
[55,56]. Within the core cell cycle network, the genes mostly
showed conserved co-expression, belonging to either O1 or O2
Figure 2. Histogram of the distances between the ETS and TCF/LEF binding sites on the promoter sequences of human and mouse
genes co-expressed in ESCs. The distances were calculated based on the midpoint of binding sites from 272 (human) or 154 (mouse) proximal
promoters bound by the two transcription factors. Negative or positive values on the plot indicate ETS is upstream or downstream of TCF/LEF on the
promoter sequence. About 75% of the genes in the conserved co-expression clusters show an 80-bp or less distance between ETS and TCF/LEF
binding sites in both human and mouse. The juxtaposed ETS and TCF/LEF binding motifs on the promoter sequences provides evidence of the FGF
response element (FRE) in the conserved co-expression clusters of ESC-critical pathways.
doi:10.1371/journal.pone.0003406.g002
Co-Expression in Stem Cells
PLoS ONE | www.plosone.org 7 October 2007 | Volume 3 | Issue 10 | e3406Figure 3. Probabilities of pathway behavior transition between ESC and EB states in response to transcriptional intervention on all
individual genes (A), top 10 double-gene combinations (B), and top 10 triple-gene combinations (C) in JAK/STAT and WNT
pathways of human and mouse. Each of the genes and gene combinations is listed for the maximum transition probability.
doi:10.1371/journal.pone.0003406.g003
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CCNA2 and CCNB2) were members of O2, up-regulated in ESCs
(Table S1). Cyclins of the G1 phase (CCND2 and CCND3), the
retinoblastoma protein (RB) and P107 (RBL1) were members of
O1, down-regulated in ESCs. Previous studies indicate that the
cell cycle in mESCs relies on constitutively active CCNA:CDK2
and CCNE:CDK2 complexes rather than an active INK4A/
CCND:CDK4/RB:E2F pathway [57,58]. Our data support these
experimental observations and further suggest that these mecha-
nisms are possibly conserved among ESCs of different species. The
up-regulation of S phase cyclins and down-regulation of G1 phase
cyclins highlights the fact that ESCs have a shortened G1 phase
and are primed for a rapid cell proliferation [55]. We furthermore
observed an up-regulation and conserved co-expression among
genes for minichromosome maintenance deficient proteins (i.e.
MCM2, MCM3, MCM4, MCM5, MCM6 and MCM7), subunits
of the origin recognition complex (ORC1, ORC2, ORC3, ORC5
and ORC6), replication proteins (RPA1, RPA2 and RPA3), and a
DNA replication initiation factor (CDC45), all of which were
members of the O2 cluster (Table S1). These results suggest that
ESCs have an elevated and tightly controlled DNA replication
activity and a shortened cell cycle, a conclusion also supported by
various experimental data from ESCs [55,58,59]. In contrast,
outside of the core cell cycle network, many cell cycle related genes
Table 3. Sums of probabilities of network transition between ESC and EB states under different transcriptional interventions
conducted on JAK/STAT and WNT pathways.
Pathway Species Single-gene intervention Double-gene intervention Triple-gene intervention
ESC-.EB EB-.ESC ESC-.EB EB-.ESC ESC-.EB EB-.ESC
JAK/STAT Human 0.0035 0.0025 0.055 0.051 0.4493 0.4486
Mouse 0.0142 0.0206 0.4378 0.4558 4.441 4.093
WNT Human 2.559e-06 3.121e-08 0.0027 0.0014 0.0556 0.0305
Mouse 7.573e-07 6.981e-07 0.0006 0.0008 0.010 0.016
doi:10.1371/journal.pone.0003406.t003
Figure 4. Cumulative distributions of functional similarities for co-expressed genes in ESC co-expression networks and random
gene pairs. The functional similarity was calculated based on the Gene Ontology terms from a) 624,491 and 637,009 pairs of co-expressed genes in
hESC and mESC networks, respectively (shown as the square-dotted/green, or triangle-dotted/blue solid lines, respectively, on the graph), b) 55,712
pairs of co-expression genes in the hESC-mESC conserved network (non-dotted/red line), and c) 250,000 randomly selected gene pairs (dash or grey
line). For the random gene pairs, the functional similarity was 8 when the cumulative probability reached 1 (i.e. all genes were analyzed). For the co-
expressed gene pairs in hESC, mESC, and hESC-mESC conserved networks, the functional similarity was over 30 when the cumulative probability
reached 1. The cumulative distributions of functional similarities from the co-expressed genes were significantly different from that of the random
gene pairs (P,10
210 by the Kolmogorov-Smirnov test). The co-expressed genes in the hESC-mESC conserved network exhibited a higher functional
similarity than the hESC or mESC network (P,10
210 by the Kolmogorov-Smirnov test on the distributions).
doi:10.1371/journal.pone.0003406.g004
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genes of the M2 cluster showed co-expression in mouse but not
human cells, including cell-cycle regulation factors (CCNC,
CCND1), CDC elements (CDC23, CDC37 and CDC37l1), and
cell-cycle phase related factors (DP1, E2F4 and SKP2). Fifteen
genes of the H2 cluster showed co-expression in human but not
mouse cells, including M-phase factors BUB1, KATNB1, MKI67,
NCAPD2, SMAC4I1 and WEE1. Taken together, our results
suggest that tight transcriptional modulation is an essential
mechanism for the core activities of the cell cycle during early
differentiation of human and mouse ESCs, while the conserved
core activities are regulated differentially by species-specific
modulation of gene expression outside the core network.
WNT Pathway
Canonical WNT signaling is important in maintaining pluripo-
tency in both human and mouse ESCs [60,61]. Our examination of
this pathway showed that the conserved co-expression mostly
occurred among downstream target genes, while key components
of this pathway were divergent on the co-expression (Tables 1 and S1,
Figure S1). In specific, among the WNT ligand genes, WNT1 and
WNT5b showed co-expression in human but not mouse cells,
WNT2, WNT2b and WNT6 showed co-expression in mouse but not
human cells, WNT3 and WNT10b showed no co-expression in both
human or mouse cells, while WNT5a was the only gene showing
conserved co-expression across species (Figure S1-E). Among the
signal transducing scaffold factors, DVL2 was co-expressed in mouse
but not human cells, while DVL3 was co-expressed in human but not
mousecells.AXIN1 and FRAT2showed co-expressioninhuman but
not in mouse, while GSK3b, CSNK1E and CTNNB1 showed co-
expression in mouse but not in human. The detailed mechanism of
WNTsignaling inregulatingESCpluripotencyisstillnotclear,based
on the experimental data [60–63]. The inhibition of G3K3B in
human and mouse ESCs [60] or PP2A in mESCs [61] indicates that
the activation of the canonical WNT pathway promotes ESC self-
renewal. However, direct activation of the WNT pathway using a
recombinant WNT3a protein demonstrates that WNT activation
promotes both self-renewal and differentiation in hESCs [62,63].
Our pathway dynamics analysis indicated that the WNT pathway is
more contributive to ESC differentiation than pluripotency mainte-
nance or induction in human cells, while equally contributive to the
two different cell fates in mouse cells. Taken together, the
experimental observations and computational analyses all suggest
that the WNT canonical pathway plays a complex role in human and
mouse ESCs, and the functions and mechanisms of WNT signaling
are not evolutionarily conserved. Our results further suggest that
despite unclear roles in ESCs, WNT5a may be important to ESC
development as a part of conserved modulation of gene expression in
canonical WNT signaling.
JAK/STAT and PI3K Pathways
Most of genes in the pathways showed a co-expression pattern,
some of which were members of conserved co-expression clusters
(Tables 1 and S1, Figure S2). As indicated in Figure S2-E, STAT3
was tightly co-expressed with JAK1 and other genes in mouse cells,
but not co-expressed in human cells. The result highlights the fact
that LIF signaling by STAT3 activation through the JAK/STAT
cascade is required in mouse, but not in human, ESCs [64,65]. On
the other hand, JAK1, P40/ISGF3G, STAT2, certain receptors
(CNTFR, GHG, IFNGR and IL10RB) and downstream target
genes (BCL2L1, CCND2 and CCND3), as well as PI3K pathway
elements (AKT1, PIK3R1, PIK3CD and PIK3R4), were co-
expressed in both human and mouse cells as members of the
conserved co-expression cluster O1 (Figure S2-E, Table S1). This
observation indicates that JAK-mediated signaling through activat-
ing STAT2 and PI3K plays a fundamental role to ESC
differentiation acrossspecies.Moreover,the conserved co-expression
among PI3K pathway members (AKT1, PIK3CD, PIK3R1 and
PIK3R4) (Table S1) suggests that transcriptional modulation in the
PI3K pathwayisanessential mechanism for bothhumanand mouse
ESCs. The fundamental role of the PI3K pathway in ESCs, as
suggested by the computational analysis, is supported by different
lines of experimental evidence. As reported, the PI3K pathway can









RUVBL1 428 1.347 1.16
GART 421 1.407 1.547
LCK 383 3.418 1.354
NOL11 382 1.082 1.09
PHC1 381 2.388 1.177
ORC2L 372 1.11 0.935
PPAT 369 1.345 0.997
TRAP1 367 0.942 0.687
C14orf156 367 1.023 0.888
NLE1 362 1.184 0.66
ORC1L 361 1.738 1.046
IGF2 360 26.529 24.548
PRIM1 360 1.422 0.613
RANBP1 359 1.043 0.854
NASP 356 1.618 1.289
NUP93 354 0.793 0.927
JARID2 352 2.106 0.979
CEBPZ 343 1.571 0.96
PRMT3 342 1.061 1.144
NHP2L1 341 0.572 0.781
Top Transcription Factor
NFYB 306 1.103 0.477
TRIM28 294 0.766 1.065
TGIF1 254 0.918 0.786
HAND1 209 25.206 20.717
POU5F1 199 2.995 1.902
HOPX 155 21.482 20.558
TFAM 149 0.845 0.682
MYCN 142 0.923 1.633
FUBP1 137 0.703 0.949
HMGA1 129 0.923 0.665
JUND 114 20.779 20.834
MEIS2 113 24.198 21.174
CREB3L1 111 20.892 20.867
CSDA 102 0.390 1.032
Positive fold-changes indicate up-regulation of genes in undifferentiated ESCs,
while negative fold-changes indicate down-regulation. The up- or down-
regulation is significant in all the genes in both hESCs and mESCs (adjusted P
value#0.05 by paired t-test). Top 20 hub genes and top transcription factors
(connectivity .100) are listed, respectively.
doi:10.1371/journal.pone.0003406.t004
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GSK3b, a WNT signaling inhibitor, in mESCs [66,67].
TGFb network
The 54 orthologous genes examined for this network include
members of ACTIVIN/NODAL and BMP pathways (Tables 1
and S1, Figure S3). The ACTIVIN/NODAL pathway showed a
conserved co-expression pattern in human and mouse cells: key
pathway components such as signal transducers SMAD2 and
SMAD3, the target and repressor gene FST and the target gene
PITX2 belonged to the conserved cluster O1, while the co-
receptor TDGF1 and antagonist LEFTB belonged to the
conserved cluster O2 (Figure S3-E). The conserved co-expression
pattern suggests that tight transcriptional modulation is an
essential mechanism for ACTIVIN/NODAL-directed signaling,
and that the pathway is fundamental in human and mouse ESCs.
Consistent with the computational analysis, experimental data
from hESCs suggest a critical role of ACTIVIN/NODAL
signaling for maintaining pluripotency [68–70]. In contrast, the
BMP pathway showed a divergent co-expression pattern across
species: key components of this pathway, such as receptors
BMPR1A (ALK3) and BMPR2, signal transducers SMAD1,
SMAD4 and SMAD5, and the target gene ID1 were co-expressed
in mouse but not in human cells (Figure S3-E, Table S1). The
divergent co-expression pattern suggests different mechanisms of
BMP signaling in human and mouse ESCs, a result consistent with
experimental data. Reportedly, in mESCs, BMP signaling through
SMAD1/5 collaborates with LIF signaling to maintain pluripo-
tency [71]. In hESCs, however, BMP signaling is suppressed and
its activation induces differentiation along the trophectoderm path
[72], while ACTIVIN/NODAL signaling through SMAD2/3
contributes to the maintenance of pluripotency [70].
AKT/PTEN Pathway
Many genes of this pathway were co-expressed, including some
key component genes that showed conserved co-expression
(Tables 1 and S1, Figure S4). In particular, PIK3R4, phospho-
lipase C (PLCB3 and PLCG2), the signal transducer PDK1, and
the downstream target gene FOXO1 belonged to the conserved
cluster up-regulated in ESCs. PIK4CA, the signal transducer
AKT1, kinases PIP5K1C, TESK1 and ITPKB, phosphatases
INPPL1, PLCD1 and INPP5A, and downstream target genes
CCND2 and CCND3 belonged to the conserved cluster down-
regulated in ESCs. Since these key pathway components, along
with downstream target genes, form tight transcriptional modu-
lation that is conserved across species, the pathway likely plays a
fundamental role in regulating ESC development.
Through the cross-species analyses of co-expression from
pathways to global networks, examination of transcriptional
factors underlying the co-expression, and exploring the dynamic
behavior of pathway via transcriptional interventions, our studies
demonstrate that evolutionary conservation at genomic, transcrip-
tomic, and network levels is an effective predictor for molecular
mechanisms regulating ESC pluripotency. The computational
approaches undertaken in these studies are effective in dealing
with the multiple complex data to indentify major target genes and
transcriptional themes, and justified by the results being frequently
supported by existing experimental data. The computational
studies provide a ‘‘road-map’’ for future experimental investiga-
tions on ESCs.
Recent breakthroughs on induced pluripotent stem cells (iPSCs)
have been considered as a milestone in science and medicine. The
cells are derived from non-pluripotent somatic cells, without the
controversial use of embryos. iPSCs are believed to be identical to
ESCs in many respects, such as the expression of signature genes
and proteins, the chromatin methylation pattern, the formation of
EBs, teratoma and viable chimera, and potency and differentiation
ability [73–75]. However, the full extent of their relation to ESCs
has not yet been determined. The question still remains on how to
characterize ‘‘pluripotent cells’’ or define ‘‘stemness’’ for stem cells
derived from different tissue sources. Our studies provide a new
avenue to address this issue. The transcriptomes of stem cells can
be readily examined by general organization properties of
biological networks. The relationship between different stem cells
can be assessed on the basis of global or pathway-specific co-
expression patterns, network hub genes, transcriptional modules,
and other network features. Mathematical modeling of dynamic
behavior of pathways, followed by gene perturbation or knock-out
experimentation, is promising in reprogramming stem cells for
directed differentiation into specific cell types, or reprogramming
somatic cells for pluripotency induction.
In summary, this study examined transcriptional co-expression
guiding ESC self-renewal and differentiation from pathways to
global networks under the framework of cross-species comparison.
Conserved or divergent co-expression patterns identified from
ESC-critical pathways suggest fundamental or species-specific
mechanisms of transcriptional modulation important for ESC
development. The promoter analysis identifying transcription
factors provides evidence of co-regulation underlying the co-
expression or modulation in the pathways. The mathematical
modeling of pathway dynamic behavior allows the identification of
genes highly contributive to network transition in response to ESC
differentiation or pluripotency induction. The global co-expression
networks provide an overall view of the organization of ESC
transcriptomes. The hub genes identified from the network are
related to important functions and possibly critical in determining
the fate of ESCs. Various novel molecular mechanisms regulating
ESC development are predicted, which could be further tested via
independent experiments. The findings and methods presented by
the studies shed light on the systems-level understanding of how
genes interact with each other to perform ESC-related functions
and how ESC pluripotency or differentiation arises from the
connectivity or networks of genes.
Materials and Methods
Genome-wide expression data
We assembled a set of genome-wide gene expression profile data
determined from different cell lines of human and mouse ESCs
and EBs from several different sources. The human ESC and EB
expression data were determined from BG01, BG02 and BG03
cell lines in our previous studies using Illumina’s BeadArrays
[5,12,76], and from H1 [3] and HES2 (E-MEXP-303 of the
ArrayExpress database) cell lines using Affymetrix chips. The
mouse ESC and EB expression data were determined from V6.5
(GSE3231 of GEO database), R1 (GSE2972) and J1 (GSE3749)
cell lines, based on Affymetrix chips. The final data sets contained
9 ESC and 9 EB (14-day differentiated) samples from human and
mouse cells, respectively. The human-mouse orthologous gene
pairs were obtained from the Affymetrix probe database. The
transcripts with low signal levels were removed, and the final list
contained 6,573 human-mouse orthologous genes. The gene
expression data were normalized using the quantile method (for
the BeadArray dataset) or the RMA method (for the Affymetrix
datasets). The normalized data were further converted into log2
ratios of expression values over the average expression value across
all the samples for each probe. The genes differentially expressed
between ESCs and EBs were identified by the paired t-test, with
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Benjamini-Hochberg algorithm. The fold-change of the gene
expression level was measured as the difference of mean
expression levels between ESCs and EBs. Positive fold-changes
indicate up-regulation of genes in undifferentiated ESCs, while
negative fold-changes indicate down-regulation.
Identification of co-expression gene clusters within
pathways
GSVD and cPAM algorithms were employed to identify
conserved and divergent co-expression patterns in pathways from
the gene expression data of human and mouse ESCs and EBs.
ATK/PTEN, CELL CYCLE, JAK/STAT (including PI3K),
TGFb (including ACTIVIN/NODAL and BMP) and WNT
pathways were examined in this study. The pathway data were
adopted from the KEGG database (www.genome.ad.jp/kegg) with
a few modifications. Table S1 lists the orthologous genes that were
examined in each pathway.
GSVD (Generalized Singular Value Decomposition). Let
the expression profile data of n genes in p samples (assume n.p)
from two species be tabulated in matrices M=[m1, m2 …mn]
T











where C and S are diagonal matrices with singular value elements
(c1, c2 …cp) and (s1, s2 …sp), respectively, and meet
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j zs2
j :1 j~1,2,   p ðÞ . U and V are column-orthogonal
matrices. The tailing matrix, T
T which relates the two datasets,
is invertible but not orthogonal [77,78]. The rows of matrix T
T, i.e.
the columns of matrix T, t1, t2 …tp, list the expression of p latent
factors, called eigengenes, across different samples in both datasets
simultaneously. The relative contribution of each eigengene to
each dataset is measured with the fraction of variance it captures,
calculated as the ratio of the square of the corresponding diagonal
element in matrix C (or S) with the sum, scaled with the length
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In defining co-expression gene clusters, two projection matrices of





The gene clusters are then identified based on the sorted
projection values under each eigengene. Genes showing
relatively high or low projection values under each eigengene
are the most corresponding to an eigengene and are grouped
together into clusters.
The conserved gene clusters are identified from the eigengene
that shows a minimal difference between singular values derived
from two datasets, as described in [78]. The difference between
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An angular distance of zero indicates an eigengene has equal
contribution or significance to both datasets. We first find the
eigengene j9 which has a minimum value of hj. We then rank genes
by sorting the projection values of two data sets under eigengene j9
(i.e. the j9 th columns of P
M and P
H). We choose two clusters CM
1
and CH
1 as the clusters containing 10% of all genes with large
projection values of two datasets under eigengene j9, and two
clusters CM
2 and CH
2 as the clusters containing 10% of genes with
small projection values of two datasets under eigengene j9. Finally
we obtain two conserved gene clusters C1 that contains common
genes between CM
1 and CH




Comparative partition around medoids (cPAM). cPAM
employs the partition around medoids (PAM) algorithm to
perform gene clustering on two different datasets. PAM is robust
to noise and outliers [79,80]. In partitioning the dataset into K
clusters, PAM minimizes the total intra-cluster variance, or, the






2, where there are K
clusters Sk, k=1,2,…, K, and mk is the medoid point of all the
points xkMSk [79,80]. The procedure starts by partitioning the input
points into K initial sets, followed by calculating the medoid of
each set. A new partition is constructed by associating each point
with the closest medoid. Then the medoids are re-calculated for
the new clusters, and the process repeats by alternative application
of these two steps until convergence is obtained, that is the points
no longer switch clusters (or alternatively medoids are no longer
changed). The results of PAM on human and mouse expression
datasets are then compared in a similar way as described in [23].
The procedure starts with assigning one species as the primary
species, and the genes are clustered according to their expression
profiles in this species. The genes of the second species are then
arranged together on the matrix according to the clusters
identified in the primary species. The procedure repeats by
assigning the second species as the primary species.
Statistical evaluation of the significance of co-expression
in each gene cluster. The statistical significance of co-
expression of each gene cluster was assessed by a random
scrambling test. For a gene cluster with n genes, Pearson’s
correlation coefficients were calculated for all gene pairs across all
samples. The average correlation coefficient (average r) of the gene
cluster was then compared with average r values of 10,000 gene
sets generated by randomly choosing n genes from all the genes in
the dataset. The frequency of having random average r values
greater or equal to the observed average r value was taken as the P
value of observing the level of co-expression in the gene cluster
with n genes.
Identification of transcription factor binding sites from
promoters
The 7 kb proximal promoter sequences of genes in each
conserved co-expression cluster were retrieved from the Promoser
database (biowulf.bu.edu/zlab). Transcription factor binding sites
were identified by searching the promoter sequences against the
vertebrate matrix data set of the Transfac 9.0 database, using the
software Match (www.gene-regulation.com). The cutoff matrix
similarity was set to 0.8 and core similarity to 0.85 in the search.
The binding sites of the transcription factor NANOG were
detected based on the consensus binding sequence (C/G)(G/A)(C/
G)C(G/C)ATTAN(G/C) [81]. The FRE was detected by
scanning ETS binding motifs (EBM) and TCF/LEF binding
Co-Expression in Stem Cells
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promoter sequence. The EBM was recognized based on the
consensus binding sequence A/CGGAA/T [82] and the TLBM
was based on CTTTGA/TA/T [83]. The transcription factors or
FREs that show binding sites in more than 50% of human genes
and mouse genes and are statistically over-represented (P
value,0.01 by Fisher’s exact test) among the genes of a cluster
are considered as significant ones underlying co-expression of that
gene cluster.
Analysis of pathway dynamic behavior
We developed an algorithm which is based on a finite-state
Markov chain model to mimic the dynamic change of a network in
response to a series of transcription interventions made in silico on
each gene or gene combination in the network [32]. The inputs to
the analysis algorithm are pathway topology and gene expression
data. The outputs are the estimated probabilities of network
transition between two states (i.e. ESCs and EBs). Prior to the
mathematical simulation, real-value gene expression data are
converted to the ternary presentation, so that each gene is assigned
as either over-expressed (1), equivalently-expressed (0), or under-
expressed (21). This is to ensure a high and uniform certainty in
specifying genes undergoing significant transcriptional changes
across different conditions.
For capturing the dynamics of the network with n selected
genes, we used the state of predictor genes at step t and the
corresponding conditional probabilities, which are estimated from
observed data, to derive the state of target gene at step t+1, as
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The transition between gene states can be represented as a
Markov chain. Considering gene perturbation, the transition
probability can be formulated by Eq. 6.
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, p is the perturbation probability







l ½  is the number of genes to be
perturbed, and p0=1/(q21). In ternary case, q=3,sop0 is equal
to 0.5.
Based on the transition matrix of the model, we constructed the
intervention information matrix H, in which the element is
defined as HK x,y ðÞ ~
P K
k~1
Fk x,y ðÞ , where Fk(x, y) can be computed
recursively as Fk x,y ðÞ ~
P
z[ {1,0,1 ½ 
n{ y fg
Ax ,z ðÞ Fk{1 z,y ðÞ for k$2
and F1(x, y)=A(x, y) for k=1. Each element A(x, y) of the transition
matrix A can be computed using Eq. 6. Each column in H
represents the probability that the network, will visit to a given
target state y, starting in all possible intervened states. Using the
intervention information matrix H, we can find the best candidate
genes that we intervene with for the highest transition probability.
We then conduct transcription intervention in silico. Three
different kinds of transcriptional interventions were conducted in
this study: a) single-gene intervention, in which a single gene was
intervened each time, across all genes, b) double-gene intervention,
in which two genes were intervened simultaneously each time,
across all two-gene combinations, and c) triple-gene intervention,
in which three genes were intervened simultaneously, across all
three-gene combinations.
Analysis of global co-expression networks
Human-mouse orthologous genes were used for constructing
global co-expression networks of human and mouse ESCs,
respectively. The Pearson correlation coefficient value (r) was first
calculated based on the expression profiles for each gene pair. The
co-expression links in the network were kept if the corresponding r
values are at or above a threshold Tr. The value of Tr is determined
according to thescale-freecriterion,whichismeasured bythesquare
ofthecorrelation coefficient (R
2) between log(P(k))andlog(k),wherek
denotes the connectivity of a node, or the number of links of a node
to other nodes in a network. P(k) gives the probability that a selected
node has exactly k links, which is calculated as the number of the
nodes (genes)at a givenk value divided by the totalnumber of nodes.
The Tr values 0.80 and 0.90 that we determined from human and
mouse data corresponded to R
2 values 0.88 and 0.84, respectively.
At or above the threshold values, genes were considered to be co-
expressed and the derived networks obeyed a power law distribution
and were scale-free. Such a scale-free criterion removed possible
spurious co-expression links and so that the resulting networks are
biologically meaningful.
The functional relevance of co-expression networks was assessed
based on the Gene Ontology (GO), in which each gene is
described by a set of GO terms. The level 3 biological process
terms in the GO database were used for this analysis. The
functional similarity of a pair of genes A and B is measured by the
number of GO terms that they share, (GOA>GOB), where GOA
or GOB denotes the set of GO terms for genes A or B. The
functional similarity is set to zero if one or both genes have no
terms. The functional similarity was calculated from co-expressed
gene pairs in the co-expression networks, as well randomly selected
gene pairs. The resulting cumulative distributions of functional
similarity scores of genes being analyzed are examined by the
Kolmogorov-Smirnov test for the statistical difference.
Supporting Information
Figure S1 The identification of conserved and divergent co-
expression gene clusters from human and mouse ESC-EB data for
the WNT pathway. The figure legends are the same as for
Figure 1.
Found at: doi:10.1371/journal.pone.0003406.s001 (1.75 MB TIF)
Figure S2 The identification of conserved and divergent co-
expression gene clusters from human and mouse ESC-EB data for
Co-Expression in Stem Cells
PLoS ONE | www.plosone.org 13 October 2007 | Volume 3 | Issue 10 | e3406the JAK/STAT pathway (incl. PI3K pathway). The figure legends
are the same as for Figure 1.
Found at: doi:10.1371/journal.pone.0003406.s002 (1.51 MB TIF)
Figure S3 The identification of conserved and divergent co-
expression gene clusters from human and mouse ESC-EB data for
the TGF-beta network (incl. ACTIVIN/NODAL and BMP
pathways). The figure legends are the same as for Figure 1.
Found at: doi:10.1371/journal.pone.0003406.s003 (1.41 MB TIF)
Figure S4 The identification of conserved and divergent co-
expression gene clusters from human and mouse ESC-EB data for
the AKT/PTEN pathway. The figure legends are the same as for
Figure 1.
Found at: doi:10.1371/journal.pone.0003406.s004 (2.08 MB TIF)
Figure S5 Topology of the hESC-mESC conserved co-expres-
sion network, with illustration of hub genes.
Found at: doi:10.1371/journal.pone.0003406.s005 (2.92 MB TIF)
Table S1 Lists of examined genes in AKT/PTEN, CELL
CYCLE, JAK/STAT (incl. PI3K), TGF-beta (incl. ACTIVIN/
NODAL and BMP) and WNT pathways, along with their
expression patterns in ESCs in comparison to EBs and
classification into conserved and divergent co-expression gene
clusters identified by GSVD and cPAM.
Found at: doi:10.1371/journal.pone.0003406.s006 (0.15 MB
XLS)
Table S2 Conserved transcription factors which showed binding
sites among most genes of both human and mouse and statistically
over-represented in a conserved co-expression cluster, and the
number of pathways where the conserved transcription factor were
present in at least one conserved co-expression cluster.
Found at: doi:10.1371/journal.pone.0003406.s007 (0.03 MB
XLS)
Table S3 Probabilities of network transition between ESC and
EB states in JAK/STAT and WNT pathways under single-,
double-, and triple-gene interventions. Transcriptional interven-
tion is presented as: transcriptional pattern at the initial state (e.g.
ESC state)=.transcription pattern after intervention=.tran-
scription pattern at the end state (e.g. EB state). In each state, the
transcription pattern of each gene are presented by ternary values
(i.e. 1, 21, 0, representing up-regulation, down-regulation, and no
change).
Found at: doi:10.1371/journal.pone.0003406.s008 (0.70 MB
XLS)
Table S4 Genes and transcription factors on the hESC, mESC,
and hESC-mESC conserved co-expression networks, along with
their expression patterns in ESCs and network connectivity (listed
from the highest to lowest).
Found at: doi:10.1371/journal.pone.0003406.s009 (1.43 MB
XLS)
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